This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CEO Of Inovalon To Participate On Payor Risk Adjustment Panel At Healthcare Growth Capital Conference

BOWIE, Md., April 11, 2013 /PRNewswire/ -- Inovalon, Inc., a leading provider of data-driven healthcare solutions, announced the participation of Keith Dunleavy, M.D., President and Chief Executive Officer of Inovalon as an executive panelist at the Healthcare Growth Capital Conference today in New York, New York.

(Logo:  http://photos.prnewswire.com/prnh/20120605/MM17779LOGO )

Dr. Dunleavy will participate as one of four panelists to discuss "Risk Adjustment and Assessment in the Payor Universe." The panel will focus on payor thinking regarding members surrounding high-cost segments of the population, healthcare reform, and at-risk models. The panel will be today, Thursday, April 11 at 4:15 p.m. (ET).

"We are proud to participate in raising the awareness regarding the challenges and opportunities within the healthcare payor landscape," said Keith Dunleavy, M.D., President and Chief Executive Officer at Inovalon. "The rapid rise of risk adjusted reimbursement models in Medicare Advantage, managed Medicaid, and now the Commercial Health Insurance Exchange Marketplace is significant. These, together with significant changes incentivizing improvements in quality outcomes and MLR performance are reshaping the payor landscape. With the advent of the Affordable Care Act, growing Medicare demographic trends, and the significant state-level trend towards privatizing Medicaid, this will only accelerate over the coming years."

The Healthcare Growth Capital Conference promotes awareness in healthcare growth platforms. The conference will provide master class support around business building best practices and a powerful forum for collaboration, networking and idea exchange among industry participants.

About Inovalon, Inc.

Inovalon, Inc. is a leading technology-enabled healthcare solutions provider focused on the importance of healthcare data and its ability to drive dramatic, objective improvement in clinical and quality outcomes, care management and financial performance throughout the healthcare community. Proprietary healthcare datasets, aggregation and analysis capabilities, combined with a national infrastructure of leading-edge technology, clinical prowess and deep human resources, empower Inovalon's advanced generation of healthcare assessment and improvement through highly informed solutions. Driven by data, Inovalon uniquely identifies gaps in care, quality, data integrity, and financial performance ­-- while also bringing to bear the resources to resolve them. This differentiating combination provides a powerful capability suite, touching more than 540,000 physicians, 220,000 clinical facilities, and more than 120 million Americans, driving high‐value impact, improving the quality and economics for health plans, hospitals, physicians, patients, and researchers. Please visit www.inovalon.com for more information.

 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs